Alterations in skin and stratified epithelia by constitutively activated PPARalpha.
Peroxisome proliferator-activated receptor (PPAR)alpha is a pleiotropic regulator in many cell types and has recently been implicated in skin homeostasis. To determine the role of PPARalpha in skin physiology, transgenic mice were generated using the tetracycline Tet-off regulatory system to target constitutively activated PPARalpha to the epidermis and other stratified epithelia by the bovine keratin K5 promoter. Expression of the transgene during early development resulted in postnatal lethality within 2 days after birth. A thin epidermis, few hair follicles, and abnormal development of the tongue were observed in neonatal transgenic mice. Early mortality was not observed when transgenic PPARalpha expression was diminished by administration of doxycycline (dox) to the mothers. The alterations noted in neonatal mice were not observed in adult mice upon re-expression of the PPARalpha transgene by withdrawing dox. Attenuated hyperplasia of interfollicular epidermis after topical application of the tumor promotor 12-O-tetradecanoyl-phorbol-13-acetate (TPA) was observed in adult mice expressing the PPARalpha transgene. In addition, expression of the PPARalpha transgene in mammary gland during pregnancy resulted in abnormal development of this organ and impaired lactation. Further investigations using primary keratinocytes revealed that expression of the transgene in keratinocytes resulted in increased differentiation and decreased proliferation, which may contribute to the observed phenotype in the transgenic mice. Thus, these results indicate that PPARalpha plays an important role in the development of stratified epithelia including skin, tongue, and mammary gland.
Yang
Qian
Q
Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Yamada
Atsushi
A
Kimura
Shioko
S
Peters
Jeffrey M
JM
Gonzalez
Frank J
FJ
D000818:Animals; D002454:Cell Differentiation; D049109:Cell Proliferation; D004318:Doxycycline / Q000494:pharmacology; D004848:Epithelium / Q000196:embryology / Q000254:growth & development; D005260:Female; D015603:Keratinocytes / Q000166:cytology / Q000378:metabolism; D007774:Lactation / Q000235:genetics; D008321:Mammary Glands, Animal / Q000254:growth & development* / Q000502:physiology; D051379:Mice; D008822:Mice, Transgenic; D047493:PPAR alpha / Q000235:genetics / Q000502:physiology*; D010703:Phorbol Esters / Q000494:pharmacology; D011247:Pregnancy; D012867:Skin / Q000166:cytology / Q000187:drug effects / Q000254:growth & development*
D047493:PPAR alpha; D010703:Phorbol Esters; D004318:Doxycycline